申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US04866091A1
公开(公告)日:1989-09-12
This invention relates to new alkane-sulfonanilide derivatives of the formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.8 are each hydrogen, cyano, halogen, lower alkyl, halo (lower) alkyl, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl or lower alkoxy, R.sup.3 is lower alkyl, R.sup.4 is acyl, cyano, carboxy, hydroxy(lower)-alkyl, mercapto, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, 5-membered unsaturated heterocyclic group which may have amino, lower alkanoylamino, lower alkylthio or lower alkylsulfonyl, phenylthio which may have nitro or amino, lower alkanoyl(lower)alkenyl or a group of the formula: ##STR2## wherein R.sup.6 is hydrogen, amino or lower alkyl and R.sup.7 is hydroxy, lower alkoxy, carboxy(lower)alkoxy, lower alkoxycarbonyl(lower)alkoxy, ureido or thioureido, and R.sup.5 is hydrogen, halogen, lower alkyl or lower alkanoyl, and pharmaceutically acceptable salts thereof. More particularly, it relates to alkanesulfonanilide derivatives and pharmaceutically acceptable salts thereof which have antiinflammatory activities and analgesic activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the treatment of inflammatory disease or pains in human being and animals".
这项发明涉及新的烷磺酰苯胺衍生物,其化学式为:##STR1## 其中R.sup.1、R.sup.2和R.sup.8分别为氢、氰基、卤素、低烷基、卤代(低)烷基、低烷基硫醚、低烷基亚砜基、低烷基磺酰基或低烷氧基,R.sup.3为低烷基,R.sup.4为酰基、氰基、羧基、羟基(低)烷基、巯基、低烷基硫醚、低烷基亚砜基、低烷基磺酰基、可能含有氨基、低烷酰胺基、低烷基硫醚或低烷基磺酰基的5-成员不饱和杂环基、可能含有硝基或氨基的苯硫醚、低烷酰(低)烯基或化学式的基团:##STR2## 其中R.sup.6为氢、氨基或低烷基,R.sup.7为羟基、低烷氧基、羧基(低)氧基、低烷氧羰基(低)氧基、脲基或硫脲基,R.sup.5为氢、卤素、低烷基或低烷酰基,及其药用盐。更具体地,它涉及具有抗炎活性和镇痛活性的烷磺酰苯胺衍生物及其药用盐,以及其制备方法、包含其的药物组合物和治疗人类和动物的炎症性疾病或疼痛的方法。